Thermo Fisher Scientific Inc.TMONYSE
Loading
Operating Cash Flow Growth TrendStable
Percentile Rank64
3Y CAGR-12.1%
5Y CAGR+18.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-12.1%/yr
Quarterly compound
5Y CAGR
+18.5%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 54.40% |
| Q3 2025 | 60.04% |
| Q2 2025 | 93.50% |
| Q1 2025 | -78.02% |
| Q4 2024 | 51.89% |
| Q3 2024 | 10.51% |
| Q2 2024 | 56.67% |
| Q1 2024 | -66.40% |
| Q4 2023 | 54.23% |
| Q3 2023 | 56.75% |
| Q3 2023 | 111.25% |
| Q2 2023 | -79.09% |
| Q4 2022 | 80.02% |
| Q4 2022 | 26.77% |
| Q3 2022 | -30.61% |
| Q2 2022 | -18.08% |
| Q4 2021 | 1.43% |
| Q4 2021 | 18.99% |
| Q3 2021 | 12.59% |
| Q2 2021 | -40.76% |
| Q4 2020 | 23.30% |
| Q3 2020 | 43.58% |
| Q2 2020 | 429.78% |
| Q1 2020 | -81.39% |
| Q4 2019 | 71.26% |
| Q3 2019 | -13.68% |
| Q2 2019 | 99.38% |
| Q1 2019 | -63.96% |
| Q4 2018 | 47.62% |
| Q3 2018 | -15.51% |
| Q2 2018 | 1751.28% |
| Q1 2018 | -95.82% |
| Q4 2017 | 101.00% |
| Q3 2017 | 9.45% |
| Q3 2017 | 134.69% |
| Q2 2017 | -70.02% |
| Q4 2016 | 56.25% |
| Q4 2016 | -13.23% |
| Q3 2016 | 207.68% |
| Q2 2016 | -76.46% |